E-LIB Suche - Ergebnisse für: Koldenhof, T

1

Brady- and tachyarrhythmias in paroxysmal atrial fibrillati..:

Park Frausing, M H J ; Van De Lande, M ; Maass, A H...
Europace. 25 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

2

Rate control with calcium channel blockers versus betablock..:

Koldenhof, T ; Van Gelder, I C ; Crijns, H J G M..
Europace. 25 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

3

The 3S-AF scheme, rather than the 4S-AF scheme, predicts pr..:

Artola, V ; Geelhoed, B ; Van Lande, M...
EP Europace. 24 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

4

The role of the autonomous nervous system in atrial fibrill..:

Van De Lande, ME ; Rajiv, RS ; Koldenhof, T...
EP Europace. 24 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

5

Rate control drugs differ in the prevention of progression ..:

Koldenhof, T ; Wijtvliet, E.P.J.P ; Pluymaekers, N.A.H.A...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

6

Brady- and tachyarrhythmias in paroxysmal atrial fibrillati..:

Park Frausing, M H J ; Van De Lande, M ; Maass, A H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207096/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Rate control with calcium channel blockers versus betablock..:

Koldenhof, T ; Van Gelder, I C ; Crijns, H J G M..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207001/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Rate control drugs differ in the prevention of progression ..:

Koldenhof, T ; Wijtvliet, P.E.P.J ; Pluymaekers, N.A.H.A...
Koldenhof , T , Wijtvliet , P E P J , Pluymaekers , N A H A , Rienstra , M , Folkeringa , R J , Bronzwaer , P , Elvan , A , Elders , J , Tukkie , R , Luermans , J G L M , van Kuijk , S M J , Tijssen , J G P , van Gelder , I C , Crijns , H J G M & Tieleman , R G 2022 , ' Rate control drugs differ in the prevention of progression of atrial fibrillation ' , EP Europace , vol. 24 , no. 3 , pp. 384-389 . https://doi.org/10.1093/europace/euab191. , 2022

Link: https://cris.maastrichtu..

9

Application of AlphaFold models in evaluating ligandable cy..:

Koldenhof, Patrick ; Bemelmans, Martijn P. ; Ghosh, Brahma...
Proteins: Structure, Function, and Bioinformatics. 92 (2024) 7 - p. 819-829 , 2024

Link: https://doi.org/10.1002/..

10

Prospective practice survey of management of cetuximab-rela..:

Lugtenberg, R. T. ; Boers-Doets, C. B. ; Witteveen, P. O....
Supportive Care in Cancer. 29 (2020) 7 - p. 3497-3506 , 2020

Link: https://doi.org/10.1007/..

11

Intermediate-mass fragments in 14N + 159Tb/natAg/natCu reac..:

Sosin, Z. ; Brzychczyk, J. ; Grotowski, K....
Nuclear Physics A. 574 (1994) 3 - p. 474-500 , 1994

Link: https://doi.org/10.1016/..

12

Prospective practice survey of management of cetuximab-rela..:

Lugtenberg, R. T ; Boers-Doets, C. B ; Witteveen, P. O...
Lugtenberg , R T , Boers-Doets , C B , Witteveen , P O , van Herpen , C M L , Wymenga , A N M , de Groot , J W B , Hoeben , A , del Grande , C , van Doorn , B , Koldenhof , J J , Driessen , C M L & Gelderblom , H 2021 , ' Prospective practice survey of management of cetuximab-related skin reactions ' , Supportive Care in Cancer , vol. 29 , no. 7 , pp. 3497-3506 . https://doi.org/10.1007/s00520-020-05862-7. , 2021

Link: https://cris.maastrichtu..

13

Prospective practice survey of management of cetuximab-rela..:

Lugtenberg, R. T ; Boers-Doets, C. B ; Witteveen, P. O...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163687/. , 2020

Link: http://www.ncbi.nlm.nih...